Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3411282)

Published in Support Care Cancer on June 27, 2012

Authors

Miroslaw Markiewicz1, Monika Dzierzak-Mietla, Andrzej Frankiewicz, Patrycja Zielinska, Anna Koclega, Malgorzata Kruszelnicka, Slawomira Kyrcz-Krzemien

Author Affiliations

1: Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland. mir.markiewicz@wp.pl

Associated clinical trials:

Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant | NCT01305200

Articles cited by this

Hematopoietic stem-cell transplantation. N Engl J Med (2006) 10.45

The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain (1983) 7.46

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer (2004) 3.83

Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer (2007) 2.95

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med (1988) 2.40

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer (2004) 2.29

Assessing the effectiveness of Dead Sea products as prophylactic agents for acute radiochemotherapy-induced skin and mucosal toxicity in patients with head and neck cancers: a phase 2 study. Isr Med Assoc J (2007) 1.98

Fluconazole-associated Stevens-Johnson syndrome. J Drugs Dermatol (2010) 1.52

Mucositis: Its Occurrence, Consequences, and Treatment in the Oncology Setting. Oncologist (1998) 1.52

A prospective study in children: Pre- and post-surgery use of vitamin E in surgical incisions. J Plast Reconstr Aesthet Surg (2009) 1.44

Oral mucositis. Anticancer Drugs (2011) 1.28

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue. Br J Haematol (2000) 1.10

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol (1994) 1.07

Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy. Support Care Cancer (1998) 1.02

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant. Bone Marrow Transplant (2007) 1.01

Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation. Bone Marrow Transplant (1995) 0.96

Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience. Transplant Proc (2011) 0.96

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant (1998) 0.94

Oropharyngeal mucositis in cancer therapy. Review of pathogenesis, diagnosis, and management. Oncology (Williston Park) (2003) 0.92

The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent (2007) 0.91

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant (2003) 0.91

The symptom experience of mucositis, stomatitis, and xerostomia. Semin Oncol Nurs (1995) 0.89

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy. Dermatology (1997) 0.89

The efficacy of antimicrobial mouth rinses in oral health care. Bull Tokyo Dent Coll (1998) 0.88

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer (2005) 0.87

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis. Br J Cancer (1988) 0.87

Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse. Bone Marrow Transplant (1988) 0.87

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study. Support Care Cancer (2005) 0.84

Relief of radiation-induced oral mucositis in head and neck cancer. Cancer Nurs (2008) 0.82

Fluconazole-induced Stevens-Johnson syndrome in a HIV-negative patient. Acta Derm Venereol (2008) 0.81

Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study. Br J Haematol (2000) 0.80

[Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma]. Ai Zheng (2003) 0.79

Survey of oral hygiene regimens among bone marrow transplant centers. Oncol Nurs Forum (1993) 0.79

Why glycerol and lemon juice? Am J Nurs (1969) 0.78

Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Am J Clin Oncol (2000) 0.77

Vitamin E and allergic contact dermatitis. Dermatitis (2010) 0.77

Articles by these authors

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. J Clin Oncol (2012) 1.56

T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome. Haematologica (2009) 1.20

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2012) 1.03

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years. Ann Hematol (2009) 0.89

Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation. Eur J Haematol (2009) 0.85

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors. Bone Marrow Res (2012) 0.82

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience. Ann Hematol (2010) 0.81

Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia? Transplantation (2014) 0.79

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study. Am J Hematol (2011) 0.77

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors. Bone Marrow Res (2012) 0.76

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation. Immunogenetics (2015) 0.75

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis. Ann Hematol (2013) 0.75

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation. Contemp Oncol (Pozn) (2012) 0.75

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience. Med Oncol (2014) 0.75

[PDT photodynamic therapy in orthopedic inflammatory conditions?]. Chir Narzadow Ruchu Ortop Pol (2006) 0.75

Myeloid neoplasms with eosinophilia and FIP1L1-PDGFRA fusion gene: another point of view. Leuk Lymphoma (2012) 0.75

Could cytogenetics and minimal residual disease replace conventional risk criteria in adults with Ph-negative acute lymphoblastic leukaemia? Br J Haematol (2008) 0.75

Impact of granulocyte colony stimulating factor administered during induction and consolidation of adults with acute lymphoblastic leukemia on survival: long-term follow-up of the Polish adult leukemia group 4-96 study. Leuk Lymphoma (2009) 0.75

Rapid reversal of quadraparesis in chronic eosinophilic leukaemia expressing the FIP1L1-PDGFRA transcript after therapy with imatinib. Leuk Res (2010) 0.75

[The opportunities of the photodynamic therapy (PDT) in bones' tumours treatment]. Chir Narzadow Ruchu Ortop Pol (2007) 0.75

Aggregates of pseudo-Gaucher cells after treatment of chronic myeloid leukemia in blastic phase. Int J Hematol (2014) 0.75